UB Paderborn / Katalog / Suche / in CDI

1,2-Benzisothiazole Derivatives Bearing 4‑, 5‑, or 6‑Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions

Journal of medicinal chemistry, 2016-07, Vol.59 (13), p.6547-6552

2016

Volltextzugriff (PDF)

IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration

Pharmacogenomics, 2016, Vol.17 (1), p.35-9

2016

Volltextzugriff (PDF)

Abstract 4375: Sunitinib alone and in combination with SN-38 is active against anaplastic thyroid cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4375-4375

2012

Volltextzugriff (PDF)

Acute pulmonary embolism and cancer: findings from the COPE study

Clinical research in cardiology, 2024-02, Vol.113 (2), p.288-300

2024

Volltextzugriff (PDF)

ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma

Frontiers in oncology, 2012, Vol.2, p.41

2012

Volltextzugriff (PDF)

Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine

European journal of pharmacology, 2004-09, Vol.498 (1), p.9-18

2004

Volltextzugriff (PDF)

Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells

Biochemical pharmacology, 2011-06, Vol.81 (11), p.1309-1316

2011

Volltextzugriff (PDF)

Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1

The journal of clinical endocrinology and metabolism, 2013-09, Vol.98 (9), p.E1465-E1473

2013

Volltextzugriff (PDF)

Atypical juvenile polymyositis: usefulness of magnetic resonance imaging

Journal of clinical rheumatology, 2008-10, Vol.14 (5), p.309

2008

Volltextzugriff (PDF)

Augmented Reality, Virtual Reality and Artificial Intelligence in Orthopedic Surgery: A Systematic Review

Applied sciences, 2021-04, Vol.11 (7), p.3253

2021

Volltextzugriff (PDF)

Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters

Rheumatic & musculoskeletal diseases open, 2023-09, Vol.9 (3), p.e003365

2023

Volltextzugriff (PDF)

Biosensors for Detection of Biochemical Markers Relevant to Osteoarthritis

Biosensors (Basel), 2021-01, Vol.11 (2), p.31

2021

Volltextzugriff (PDF)

BMI Reduction Decreases AF Recurrence Rate in a Mediterranean Cohort

Journal of the American College of Cardiology, 2015-11, Vol.66 (20), p.2264-2265

2015

Volltextzugriff (PDF)

Bovine Serum Amine Oxidase and Polyamine Analogues: Chemical Synthesis and Biological Evaluation Integrated with Molecular Docking and 3‑D QSAR Studies

Journal of chemical information and modeling, 2022-08, Vol.62 (16), p.3910-3927

2022

Volltextzugriff (PDF)

Calcium calmodulin kinase II activity is required for cartilage homeostasis in osteoarthritis

Scientific reports, 2021-03, Vol.11 (1), p.5682-5682, Article 5682

2021

Volltextzugriff (PDF)

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics

Biochemical pharmacology, 2019-06, Vol.164, p.94-105

2019

Volltextzugriff (PDF)

Circulating angiogenic factors as predictors of benefit from bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Translational analyses from the phase III BEBYP trial

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.382-382

2013

Volltextzugriff (PDF)

Circulating angiogenic factors as predictors of benefit from bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Traslational analyses from the phase III BEBYP trial

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3603-3603

2013

Volltextzugriff (PDF)

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

Clinical cancer research, 2009-08, Vol.15 (15), p.4954-4962

2009

Volltextzugriff (PDF)

Clinical Impact of Balneotherapy and Therapeutic Exercise in Rheumatic Diseases: A Lexical Analysis and Scoping Review

Applied sciences, 2022-08, Vol.12 (15), p.7379

2022

Volltextzugriff (PDF)

Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients

Investigational new drugs, 2016-12, Vol.34 (6), p.760-770

2016

Volltextzugriff (PDF)

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers

Angiogenesis (London), 2012-06, Vol.15 (2), p.275-286

2012

Volltextzugriff (PDF)

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo

Molecular and cellular endocrinology, 2014-08, Vol.393 (1-2), p.56-64

2014

Volltextzugriff (PDF)

CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In Vivo

The journal of clinical endocrinology and metabolism, 2014-04, Vol.99 (4), p.E572-E581

2014

Volltextzugriff (PDF)

CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancer in Vitro and in Vivo

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.E528-E536

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

1,2-Benzisothiazole Derivatives Bearing 4‑, 5‑, or 6‑Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions

IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration

Abstract 4375: Sunitinib alone and in combination with SN-38 is active against anaplastic thyroid cancer

Acute pulmonary embolism and cancer: findings from the COPE study

ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma

Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine

Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells

Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1

Atypical juvenile polymyositis: usefulness of magnetic resonance imaging

Augmented Reality, Virtual Reality and Artificial Intelligence in Orthopedic Surgery: A Systematic Review

Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters

Biosensors for Detection of Biochemical Markers Relevant to Osteoarthritis

BMI Reduction Decreases AF Recurrence Rate in a Mediterranean Cohort

Bovine Serum Amine Oxidase and Polyamine Analogues: Chemical Synthesis and Biological Evaluation Integrated with Molecular Docking and 3‑D QSAR Studies

Calcium calmodulin kinase II activity is required for cartilage homeostasis in osteoarthritis

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics

Circulating angiogenic factors as predictors of benefit from bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Translational analyses from the phase III BEBYP trial

Circulating angiogenic factors as predictors of benefit from bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Traslational analyses from the phase III BEBYP trial

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

Clinical Impact of Balneotherapy and Therapeutic Exercise in Rheumatic Diseases: A Lexical Analysis and Scoping Review

Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo

CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In Vivo

CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancer in Vitro and in Vivo

Suchergebnisse filtern